https://european-biotechnology.net/wp-content/uploads/2024/12/deeplife-team.webp470780Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-17 08:09:562024-12-18 12:02:03DeepLife raises US$10m in Series A financing
https://european-biotechnology.net/wp-content/uploads/2024/12/Noema-e1733906107756-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-11 08:36:072024-12-12 10:02:07Noema Pharma AG extends Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/12/Dewpoint-e1733404904642-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-06 08:02:582024-12-12 10:02:07Dewpoint Therapeutics and Mitsubishi Tanabe partner on ALS therapy
https://european-biotechnology.net/wp-content/uploads/2024/12/Eli_Lilly_vials-e1733390268973.jpg225400Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-05 09:18:342024-12-12 10:02:07UK first country in Europe to reimburse tirzepatide
